January 2024 - Page 29 of 272

NASDAQ Companies - January 30, 2024

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated […]

NASDAQ Companies - January 30, 2024

RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform

LAKEWOOD, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance” or the “Company”), today […]

NASDAQ Companies - January 30, 2024

CorMedix Inc. Announces Commercial and Reimbursement Updates

BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]

NASDAQ Companies - January 30, 2024

Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)

MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics […]

NYSE Companies - January 30, 2024

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”

NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) — Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a […]

NYSE Companies - January 30, 2024

Freedom of Mobility Forum Announces 2024 Topic, Expert Panelists and University Participants for Second Annual Live Debate on April 3

Freedom of Mobility Forum Announces 2024 Topic, Expert Panelists and University Participants for Second Annual Live Debate on April 3 […]

NASDAQ Companies - January 30, 2024

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

RELI Exchange Launches the Client Referral Portal into its Proprietary InsurTech Platform

CorMedix Inc. Announces Commercial and Reimbursement Updates

Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”

Freedom of Mobility Forum Announces 2024 Topic, Expert Panelists and University Participants for Second Annual Live Debate on April 3

Franklin Electric Schedules Its Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

mdf commerce announces the date of the conference call for third quarter of fiscal year 2024 financial results

BT Group Selects Optiva for Next-Generation Application Server Upgrade to Build and Deploy Innovative New Services

Copper Lake Provides Exploration Update on Its Marshall Lake Copper-Zinc-Silver VMS Property, Northwestern Ontario